LeMaitre Vascular (LMAT)
LeMaitre Vascular Revenues: 13.93M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
LMAT Revenues Rankings
| Overall | 17th percentile | 3675 of 4432 |
| Sector | 38th percentile | 290 of 470 in Healthcare |
| Industry | 34th percentile | 44 of 67 in Medical Instruments & Supplies |
LMAT Revenues Range, Past 5 Years
| Minimum | 10.14M | Sep 2007 |
| Maximum | 15.11M | Jun 2011 |
| Average | 12.94M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these LMAT related companies
LMAT News
LeMaitre Vascular to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
May 10, 5:17PM GlobeNewswire
May 10, 5:17PM GlobeNewswire
Canaccord Genuity Maintains a 'Buy' on LeMaitre Vascular (LMAT); Mixed Q1
May 03, 9:49AM Street Insider
May 03, 9:49AM Street Insider
LeMaitre Vascular's CEO Discusses Q1 2012 Results - Earnings Call Transcript
May 02, 9:30PM Seeking Alpha
May 02, 9:30PM Seeking Alpha
LeMaitre Vascular Q1 2012 Sales $13.9mm (+8% Organic), Op. Profit $0.9mm
May 02, 4:00PM GlobeNewswire
May 02, 4:00PM GlobeNewswire
$LMAT forms bearish "Descending Continuation Triangle" chart pattern. http://stks.co/3W9Q
about 34 days ago by RecogniaEvents
about 34 days ago by RecogniaEvents
LeMaitre Vascular, Inc. Schedules First Quarter Results and Conference Call
Apr 20, 9:42AM GlobeNewswire
Apr 20, 9:42AM GlobeNewswire
LeMaitre Vascular's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Feb 27, 8:57PM Seeking Alpha
Feb 27, 8:57PM Seeking Alpha
LeMaitre Vascular, Inc. (LMAT) Reports Q4 Earnings of $0.02; Guides Q1, FY12 Revs
Feb 27, 4:09PM Street Insider
Feb 27, 4:09PM Street Insider
LeMaitre Vascular Q4 2011 Sales $13.4mm (+5% Organic), Op. Profit $0.8mm
Feb 27, 4:05PM GlobeNewswire
Feb 27, 4:05PM GlobeNewswire
LeMaitre Vascular, Inc. Schedules Fourth Quarter Results and Conference Call
Feb 16, 4:44PM GlobeNewswire
Feb 16, 4:44PM GlobeNewswire
LeMaitre Vascular to Present at the Sidoti & Company Micro Cap Conference
Jan 09, 11:14AM GlobeNewswire
Jan 09, 11:14AM GlobeNewswire
LeMaitre Vascular to Present at the Canaccord Genuity Cardiovascular Conference
Dec 01, 3:49PM GlobeNewswire
Dec 01, 3:49PM GlobeNewswire
LeMaitre Vascular Doubles Its Stock Repurchase Program From $5mm to $10mm
Nov 09, 2:40PM GlobeNewswire
Nov 09, 2:40PM GlobeNewswire
Canaccord Genuity Maintains a 'Buy' on LeMaitre Vascular (LMAT); Mixed Q3; Lowering Price Target
Oct 28, 9:56AM Street Insider
Oct 28, 9:56AM Street Insider
LeMaitre Vascular, Inc. Schedules Third Quarter Results and Conference Call
Oct 14, 3:13PM GlobeNewswire
Oct 14, 3:13PM GlobeNewswire
LeMaitre Vascular to Present at the Stifel Nicolaus Healthcare Conference 2011
Aug 29, 10:55AM GlobeNewswire
Aug 29, 10:55AM GlobeNewswire
LeMaitre Vascular to Present at the Canaccord Genuity Annual Growth Conference
Aug 08, 3:23PM GlobeNewswire
Aug 08, 3:23PM GlobeNewswire
$LMAT http://chart.ly/7nu4ffl Like the trend even though funadmanetals not too stable, IBD rating 91
about 627 days ago by redman59
about 627 days ago by redman59
$LMAT http://chart.ly/7nwnj94 making new highs.. could really run
about 643 days ago by mb_willoughby
about 643 days ago by mb_willoughby
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| LMAT | 5.30 | +0.13 | +2.50% | 81.67M |
| LM | 26.14 | +0.62 | +2.43% | 3.653B |
| LLY | 41.30 | +0.19 | +0.46% | 47.92B |
| LKQX | 36.28 | +0.75 | +2.11% | 5.345B |
| LKFN | 25.61 | +0.24 | +0.95% | 417.44M |
| LIZ | 13.00 | +0.00 | +0.00% | 1.313B |
| LIWA | 5.32 | +0.00 | +0.00% | 160.03M |
| LIVE | 6.17 | +0.04 | +0.65% | 14.50M |
| LIOX | 3.07 | +0.05 | +1.66% | 193.29M |
| LINTB | 17.32 | +0.00 | +0.00% | 10.22B |
